There were no significant differences in the expression levels of TGFβ receptors (TGFβRI-II) and Smads (Smad2, Smad3, Smad4) mRNAs between ccRCC and the corresponding NK tissues. The gene discussed is SMAD2; the disease is nonpapillary renal cell carcinoma.